Detalles de la búsqueda
1.
Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.
Transfusion
; 60(5): 922-931, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358836
2.
Factors associated with self-reported anal cancer screening history in men who have sex with men.
Sex Health
; 16(1): 96-98, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30517839
3.
A phase II clinical study to assess the feasibility of self and partner anal examinations to detect anal canal abnormalities including anal cancer.
Sex Transm Infect
; 94(2): 124-130, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28835533
4.
A qualitative investigation among men who have sex with men on the acceptability of performing a self- or partner anal exam to screen for anal cancer.
Cancer Causes Control
; 28(10): 1157-1166, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779467
5.
Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.
Transfusion
; 55(6): 1331-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25823522
6.
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
JAMA
; 313(5): 471-82, 2015 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25647203
7.
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
J Gen Intern Med
; 29(11): 1475-83, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25002161
8.
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Circulation
; 124(17): 1811-8, 2011 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21969009
9.
Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.
Am Heart J
; 164(6): 925-31.e2, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23194494
10.
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA
; 307(16): 1717-26, 2012 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22447880
11.
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA
; 308(22): 2380-9, 2012 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129008
12.
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
Am Heart J
; 162(6): 973-80, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22137069
13.
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA
; 306(19): 2110-9, 2011 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22084195
14.
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
Am Heart J
; 160(2): 215-23, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20691824
15.
Management of blunt cerebrovascular injury (BCVI) in the multisystem injury patient with contraindications to immediate anti-thrombotic therapy.
Injury
; 49(1): 67-74, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28789779
16.
Constraint-induced movement therapy during early stroke rehabilitation.
Neurorehabil Neural Repair
; 21(1): 14-24, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17172550
17.
Dependence, hyper-dependence and hypothesis testing in clinical trials.
Contemp Clin Trials
; 28(1): 68-78, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16857430
18.
Outcomes after concomitant traumatic brain injury and hemorrhagic shock: A secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios trial.
J Trauma Acute Care Surg
; 83(4): 668-674, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28930959
19.
Argatroban tPA stroke study: study design and results in the first treated cohort.
Arch Neurol
; 63(8): 1057-62, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16908730
20.
Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience.
Injury
; 47(10): 2131-2137, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27476886